The narrative around OpenAI has completely flipped, challenging Oracle's justification of borrowing money to fund artificial ...

Oracle's debt is on the rise. Free cash flow is very much in the red. Oracle's leverage makes it a high-risk, high-potential-reward opportunity in AI. 10 stocks we like better than Oracle › Oracle ...

Oracle’s stock has dropped 19% within just one month, unsettling investors who previously witnessed its rise earlier this year. The decline began after a revenue miss in the December quarter, but a ...

Oracle (NYSE: ORCL) reported quarterly financial results that underwhelmed stock market investors. *Stock prices used were the afternoon prices of Dec. 10, 2025. The video was published on Dec. 12, ...

Oracle is confirmed as a Buy, despite a post-earnings sell-off and near-term volatility. ORCL's cloud segment surged 34% YoY, now its primary growth engine, while legacy software declined 3%. Massive ...

Over the past decade, Oracle stock (NYSE: ORCL) has emerged as a premier capital-return engine, distributing a remarkable $158 billion to shareholders—the 9th highest total in corporate history. This ...

Oracle ORCL has embarked on an aggressive infrastructure expansion strategy that positions the enterprise software giant at the center of the artificial intelligence revolution, yet this bet comes ...

Oracle's (NYSE: ORCL) stock price is falling, and investors are curious about the causes. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to ...

What To Know: The Financial Times reported on Wednesday that Blue Owl Capital (NYSE:OWL) , Oracle’s biggest data center partner, has decided not to support a $10 billion deal for its next planned data ...

The tech sector sold off as investors took in a report that Oracle's $10B data center for OpenAI is in jeopardy. Sources told the FT that talks to build the data center have stalled due to concerns ...

Oracle on Thursday announced Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to empower pharmaceutical, medical device, research and life sciences organizations to ...